To determine if the expression of IRs on CD8 TILs associates with any clinical characteristics, we investigated 54 cervical cancer patients of whom 20 are blood-tumor tissue-matched patients and 34 are tumor tissue-only patients in our clinical cohort. This evidence concerns the gene CD8A and cervical carcinoma.